Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal liver failure.

Patricia McClean1, Suzanne M Davison

  • 1Children's Liver and GI Unit, St James's, University Hospital, Beckett Street, Leeds LS9 7TF, UK. patricia.mcclean@leedsth.nhs.uk

Seminars in Neonatology : SN
|March 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic landscape of pediatric acute liver failure of indeterminate origin.

Hepatology (Baltimore, Md.)·2023
Same author

Healthcare transition in pediatric liver transplantation: The perspectives of pediatric and adult healthcare professionals.

Pediatric transplantation·2019
Same author

Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.

Journal of inherited metabolic disease·2019
Same author

The Experiences of Young Liver Patients Transferring From Children's to Adult Services and Their Support Needs for a Successful Transition.

Progress in transplantation (Aliso Viejo, Calif.)·2018
Same author

Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.

Hepatology communications·2018
Same author

SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN).

Genetics in medicine : official journal of the American College of Medical Genetics·2018
Same journal

Role of micro-organisms in necrotizing enterocolitis.

Seminars in neonatology : SN·2020
Same journal

The epidemiology and pathogenesis of necrotizing enterocolitis.

Seminars in neonatology : SN·2020
Same journal

Regionalized perinatal education.

Seminars in neonatology : SN·2005
Same journal

Regional quality assessment in perinatal care.

Seminars in neonatology : SN·2005
Same journal

Regionalized long-term follow-up.

Seminars in neonatology : SN·2005
Same journal

Regionalized neonatal emergency transport.

Seminars in neonatology : SN·2005
See all related articles

Neonatal liver failure presents diagnostic and management challenges, but advances in metabolic disorder treatments and liver transplantation have improved survival rates. Early intervention and specialized care are crucial for better outcomes in affected infants.

Area of Science:

  • Pediatric Hepatology
  • Neonatal Medicine
  • Transplantation Surgery

Background:

  • Neonatal liver failure is a critical condition with high mortality.
  • Advances in metabolic disorder treatments and antiviral therapies are emerging.
  • Pediatric liver transplantation is increasingly viable for infants.

Purpose of the Study:

  • To summarize the current state of neonatal liver failure management.
  • To highlight the impact of recent therapeutic developments.
  • To emphasize the importance of early diagnosis and specialized care.

Main Methods:

  • Review of current literature on neonatal liver failure.
  • Analysis of survival rates with modern interventions.
  • Discussion of challenges in transplantation decision-making.

Related Experiment Videos

Main Results:

  • An overall survival rate of 40% has been achieved.
  • Early recognition and supportive care improve outcomes.
  • Liver transplantation offers a viable option for select infants.

Conclusions:

  • Prompt referral to pediatric liver transplant centers is essential.
  • Transplantation decisions require careful consideration of evolving conditions.
  • Management strategies must address both hepatic and potential extrahepatic diseases.